CLINICAL_TRIALS
trial_result
· 2015-12-18
Clinical Trial Update: An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma [Phase 3]
Summary
Phase 3 extended-use study of talimogene laherparepvec (T-VEC) in melanoma completed; results assessing safety and efficacy have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: BioVex Limited | Conditions: Melanoma | Phase 3 | Status: COMPLETED | Results posted: 2015-12-18